Avanos Medical Valuation Multiples

Discover Avanos Medical's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Tandem Diabetes Care, Shinva, Arcs Co, QuidelOrtho and more.

Avanos Medical Overview

About Avanos Medical

Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.


Founded

2014

HQ

United States

Employees

2.3K

Website

avanos.com

Financials (LTM)

Revenue: $706M
EBITDA: $87M

EV

$1.2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Avanos Medical Financials

Avanos Medical reported last 12-month revenue of $706M and EBITDA of $87M.

In the same LTM period, Avanos Medical generated $388M in gross profit, $87M in EBITDA, and $43M in net income.

Revenue (LTM)


Avanos Medical P&L

In the most recent fiscal year, Avanos Medical reported revenue of $701M and EBITDA of $87M.

Avanos Medical is profitable as of last fiscal year, with gross margin of 50%, EBITDA margin of 12%, and net margin of 6%.

See analyst estimates for Avanos Medical
LTMLast FY202320242025202620272028
Revenue$706M$701M$673M$688M$701M
Gross Profit$388M$354M$380M$381M$354M
Gross Margin55%50%56%55%50%
EBITDA$87M$87M$53M($346M)($20M)
EBITDA Margin12%12%8%(50%)(3%)
EBIT Margin10%10%1%6%2%
Net Profit$43M$43M($62M)($392M)($73M)
Net Margin6%6%(9%)(57%)(10%)
Net Debt-$11M---

Financial data powered by Morningstar, Inc.

Avanos Medical Stock Performance

Avanos Medical has current market cap of $1.2B, and enterprise value of $1.2B.

Market Cap Evolution


Avanos Medical's stock price is $24.97.

Avanos Medical share price increased by 0.4% in the last 30 days, and by 123.5% in the last year.

Avanos Medical has an EPS (earnings per share) of $0.93.

See more trading valuation data for Avanos Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1.2B$1.2B0.0%0.4%1.4%123.5%$0.93

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Avanos Medical Valuation Multiples

Avanos Medical trades at 1.8x EV/Revenue multiple, and 14.3x EV/EBITDA.

See NTM and 2027E valuation multiples for Avanos Medical

EV / Revenue (LTM)


Avanos Medical Financial Valuation Multiples

As of July 19, 2026, Avanos Medical has market cap of $1.2B and EV of $1.2B.

Avanos Medical has a P/E ratio of 27.0x.

LTMLast FY202320242025202620272028
EV/Revenue1.8x1.8x1.8x1.8x1.8x
EV/EBITDA14.3x14.3x23.4x(3.6x)(63.7x)
EV/EBIT18.5x18.5xn/m30.7x80.7x
EV/Gross Profit3.2x3.5x3.3x3.3x3.5x
P/E27.0x27.0x(18.9x)(3.0x)(16.0x)
EV/FCF28.8x28.8x85.1x15.0x28.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Avanos Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Avanos Medical Margins & Growth Rates

Avanos Medical grew revenue by 1% in the last fiscal year.

In the most recent fiscal year, Avanos Medical reported gross margin of 50%, EBITDA margin of 12%, and net margin of 6%.

See estimated margins and future growth rates for Avanos Medical

Avanos Medical Margins

Last FY20242025202720282029
Gross Margin50%55%50%
EBITDA Margin12%(50%)(3%)
EBIT Margin10%6%2%
Net Margin6%(57%)(10%)
FCF Margin6%12%6%

Avanos Medical Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth1%2%2%1%
Gross Profit Growth-0%(7%)-
EBITDA Growth-(750%)(94%)-
EBIT Growth-864%(62%)-
Net Profit Growth-534%(81%)-
FCF Growth-468%(48%)-

Data powered by FactSet, Inc. and Morningstar, Inc.

Avanos Medical Operational KPIs

Avanos Medical's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for Avanos Medical
LTMLast FY202320242025202620272028
Rule of 4015%----
Bessemer Rule of X20%----
Revenue per Employee-$0.3M---
Opex per Employee-$0.1M---
R&D Expenses to Revenue3%3%4%4%3%
Opex to Revenue-48%56%50%48%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Avanos Medical Competitors

Avanos Medical competitors include Tandem Diabetes Care, Shinva, Arcs Co, QuidelOrtho, SonoScape, Artivion, Alpha Tau Medical, ChemoMetec, VCANBIO and iRadimed.

Most Avanos Medical public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Tandem Diabetes Care1.3x1.3x(28.9x)139.4x
Shinva0.6x0.6x6.9x6.8x
Arcs Co0.2x0.2x4.3x4.3x
QuidelOrtho1.4x1.4x6.6x6.4x
SonoScape3.0x2.8x25.4x20.8x
Artivion3.2x3.0x15.8x15.4x
Alpha Tau Medical-1748.7x(28.4x)(24.4x)
ChemoMetec13.7x13.5x26.3x24.6x

This data is available for Pro users. Sign up to see all Avanos Medical competitors and their valuation data.

Start Free Trial

Acquisitions by Avanos Medical

Avanos Medical has acquired 5 companies to date.

Last acquisition by Avanos Medical was on September 15th 2025. Avanos Medical acquired Nexus Medical for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Avanos Medical

Nexus Medical
Diros Technology
OrthogenRx
Game Ready
Description
Nexus Medical is a Salt Lake City-headquartered manufacturer of needle-free valves and IV connectors for infusion therapy. The ClearLine and SwabCap products reduce catheter-related bloodstream infections in hospitals. Founded in 2003, Nexus Medical supplies systems to Cleveland Clinic and Mayo Clinic compliant with ISO 80369 standards.
Diros Technology is a Tel Aviv-headquartered medical device company specializing in radiofrequency ablation systems for chronic pain management and neurosurgery. The firm develops the PainBox RF generator alongside specialized probes such as the RF Trident multi-needle electrode and various RF cannulae designed for precise denervation. These tools target conditions including cervical radiculopathy, thoracic pain, lumbar facet joint pain, sacroiliac joint dysfunction, and trigeminal neuralgia. Established in 2002, Diros Technology serves interventional pain specialists and neurosurgeons worldwide with CE-marked and FDA-cleared products emphasizing safety features like impedance monitoring and lesion visualization.
OrthogenRx is a Pennsylvania-based commercial-stage company marketing generic orthopedic devices for musculoskeletal conditions. Through 510(k) clearances, it supplies hip, knee, and extremity implants identical to predicate devices but at reduced costs. Exclusive licenses enable U.S. distribution of ex-U.S. approved products like fracture fixation plates and screws.
-
HQ CountryUnited StatesCanadaUnited StatesUnited States
HQ City
Kansas City, KS
Toronto
Philadelphia, PA
Alpharetta, GA
Deal Date15 Sep 202519 Jun 202313 Dec 20215 Jun 2018
Valuationundisclosed$60M$160M$65M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Avanos Medical acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Avanos Medical

Avanos Medical has invested in 1 company to date.

Latest investment by Avanos Medical was on November 15th 2024. Avanos Medical invested in Synaptrix in their $10M Series A round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Avanos Medical

Synaptrix
Description
Synaptrix is a healthcare innovator providing NOVABLOC cryoanalgesia technology for drug-free postoperative pain management. The system applies targeted nerve freezing during surgeries to deliver pain relief lasting three to six months, used in knee replacements, shoulder repairs, and thoracic procedures.
HQ CountryUnited States
HQ City
Alpharetta, GA
Deal Date15 Nov 2024
RoundSeries A
Raised$10M
InvestorsPortal Innovations; Avanos Medical; Rex Health Ventures; Hatteras Venture Partners
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Avanos Medical investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Avanos Medical

When was Avanos Medical founded?Avanos Medical was founded in 2014.
Where is Avanos Medical headquartered?Avanos Medical is headquartered in United States.
How many employees does Avanos Medical have?As of today, Avanos Medical has over 2K employees.
Who is the CEO of Avanos Medical?Avanos Medical's CEO is David C. Pacitti.
Is Avanos Medical publicly listed?Yes, Avanos Medical is a public company listed on NYSE.
What is the stock symbol of Avanos Medical?Avanos Medical trades under AVNS ticker.
When did Avanos Medical go public?Avanos Medical went public in 2014.
Who are competitors of Avanos Medical?Avanos Medical main competitors include Tandem Diabetes Care, Shinva, Arcs Co, QuidelOrtho, SonoScape, Artivion, Alpha Tau Medical, ChemoMetec, VCANBIO, iRadimed.
What is the current market cap of Avanos Medical?Avanos Medical's current market cap is $1.2B.
What is the current revenue of Avanos Medical?Avanos Medical's last 12 months revenue is $706M.
What is the current revenue growth of Avanos Medical?Avanos Medical revenue growth (NTM/LTM) is 3%.
What is the current EV/Revenue multiple of Avanos Medical?Current revenue multiple of Avanos Medical is 1.8x.
What is the current EBITDA of Avanos Medical?Avanos Medical's last 12 months EBITDA is $87M.
What is Avanos Medical's EBITDA margin?Avanos Medical's last 12 months EBITDA margin is 12%.
What is the current EV/EBITDA multiple of Avanos Medical?Current EBITDA multiple of Avanos Medical is 14.3x.
What is the current FCF of Avanos Medical?Avanos Medical's last 12 months FCF is $43M.
What is Avanos Medical's FCF margin?Avanos Medical's last 12 months FCF margin is 6%.
What is the current EV/FCF multiple of Avanos Medical?Current FCF multiple of Avanos Medical is 28.8x.
How many companies Avanos Medical has acquired to date?As of July 2026, Avanos Medical has acquired 5 companies.
What was the largest acquisition by Avanos Medical?$174M acquisition of CORPAK MedSystems on 10th April 2016 was the largest M&A Avanos Medical has done to date.
What companies Avanos Medical acquired?Avanos Medical acquired CORPAK MedSystems, OrthogenRx, Game Ready, Diros Technology, and Nexus Medical.
In how many companies Avanos Medical has invested to date?As of July 2026, Avanos Medical has invested in 1 company.
What was the last Avanos Medical investment?On 15th November 2024 Avanos Medical invested in Synaptrix, participating in a $10M Series A round, alongside Portal Innovations, Rex Health Ventures, and Hatteras Venture Partners.
In what companies Avanos Medical invested in?Avanos Medical invested in Synaptrix.

See public comps similar to Avanos Medical

Lists including Avanos Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial